Victory Capital Management Inc Reata Pharmaceuticals Inc Transaction History

Victory Capital Management Inc

$99 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 27, 2023	BUY	$79.22 - $105.37 $3.98 Million - $5.29 Million	50,249 Added 31.08%	211,931 $21.6 Million
Q1 2023 May 02, 2023	BUY	$30.85 - $93.17 $4.99 Million - $15.1 Million	161,682 New	161,682 $14.7 Million
Q3 2022 Nov 02, 2022	BUY	$19.41 - $36.49 $12,635 - $23,754	651 Added 5.9%	11,690 $294,000
Q2 2022 Aug 01, 2022	SELL	$20.71 - $36.5 $289 - $511	-14 Reduced 0.13%	11,039 $335,000
Q1 2022 May 04, 2022	SELL	$24.12 - $39.6 $1,760 - $2,890	-73 Reduced 0.66%	11,053 $281,000
Q4 2021 Feb 07, 2022	SELL	$25.61 - $110.96 $37,877 - $164,109	-1,479 Reduced 11.73%	11,126 $293,000
Q3 2021 Nov 02, 2021	SELL	$100.0 - $143.02 $13,200 - $18,878	-132 Reduced 1.04%	12,605 $1.27 Million
Q2 2021 Aug 03, 2021	SELL	$78.27 - $151.29 $45,161 - $87,294	-577 Reduced 4.33%	12,737 $1.8 Million
Q1 2021 May 04, 2021	SELL	$94.25 - $132.81 $62,016 - $87,388	-658 Reduced 4.71%	13,314 $1.33 Million
Q4 2020 Feb 01, 2021	SELL	$102.03 - $184.62 $163,452 - $295,761	-1,602 Reduced 10.29%	13,972 $1.73 Million
Q3 2020 Nov 09, 2020	SELL	$93.53 - $163.34 $547,150 - $955,539	-5,850 Reduced 27.31%	15,574 $1.52 Million
Q2 2020 Aug 07, 2020	BUY	$126.3 - $176.56 $37,637 - $52,614	298 Added 1.41%	21,424 $3.34 Million
Q1 2020 May 04, 2020	SELL	$124.16 - $247.74 $47,056 - $93,893	-379 Reduced 1.76%	21,126 $3.05 Million
Q4 2019 Feb 06, 2020	BUY	$74.57 - $217.92 $76,881 - $224,675	1,031 Added 5.04%	21,505 $4.4 Million
Q4 2019 Feb 04, 2020	SELL	$74.57 - $217.92 $512,146 - $1.5 Million	-6,868 Reduced 25.12%	20,474 $4.48 Million
Q3 2019 Nov 12, 2019	BUY	$71.26 - $95.75 $1.9 Million - $2.56 Million	26,697 Added 4139.07%	27,342 $2.2 Million
Q2 2019 Aug 15, 2019	SELL	$77.72 - $94.35 $25,025 - $30,380	-322 Reduced 33.3%	645 $61,000
Q4 2018 Feb 05, 2019	SELL	$48.76 - $76.44 $8,971 - $14,064	-184 Reduced 15.99%	967 $54,000
Q3 2018 Nov 01, 2018	BUY	$35.64 - $92.06 $5,381 - $13,901	151 Added 15.1%	1,151 $94,000
Q1 2018 May 04, 2018	SELL	$20.0 - $30.19 $473,400 - $714,597	-23,670 Reduced 95.95%	1,000 $21,000
Q4 2017 Feb 01, 2018	BUY	$22.39 - $33.27 $60,229 - $89,496	2,690 Added 12.24%	24,670 $698,000
Q3 2017 Oct 27, 2017	BUY	$26.29 - $31.88 $24,975 - $30,286	950 Added 4.52%	21,980 $683,000
Q2 2017 Aug 07, 2017	BUY	N/A	21,030	21,030 $665,000

Others Institutions Holding RETA

# of Institutions

Shares Held

62.7K

Call Options Held

Put Options Held

View Full List

About REATA PHARMACEUTICALS INC

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

More about RETA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account